Covalon Technologies Ltd V.COV

Buzz on the Bullboards: Aviation, cannabis, and industrial stocks undeterred by tariff drama

[Possibleidiot01]

COV.V - Covalon Technologies LTD   Covalon Technologies (COV.V) reported its Q2 2025 with revenue of CA$7.586 million, down 10% from CA$8.414 million in Q2 2024, due to a dip in U.S. advanced

[Jonathon Brown]

Even with Wall Street operating on a shortened schedule due to the Memorial Day holiday, the TSX hit two fresh highs twice this week. read article.

[Possibleidiot01]

https://substack.com/home/post/p-164819463 How about Covalon? Q2 revenue of $7.6 million led by strong growth in the U.S. Vascular Access and Surgical Consumables business as well as the

[PressRelease]

Year-To-Date Revenue Grew 21% and Year-To-Date Adjusted EBITDA Increased by 57% Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, today announced its fiscal 2025 second quarter results for the period ended March 31, 2025,...read article.

[Possibleidiot01]

Company must feel pretty confident about the results especiallly since they won't be presented till the fall. Study results have been selected for presentation at two prestigious scientific

[PressRelease]

Study results have been selected for presentation at two prestigious scientific meetings and are advancing to publication Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, today announced that exciting results from a...read article.

[PressRelease]

Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, will release its Q2 Fiscal 2025 financial results on Wednesday, May 28, 2025, before markets open. A conference call and webcast to discuss the financial results will be...read article.

[prophetoffactz]

Thanks. My information was based on the 2024 annual results: Full year 2024 Adjusted EBITDA of $4.8 million ($7.5 million improvement over full year 2023)

[Possibleidiot01]

Can I ask where you got $4.8 million from? AI. Here's what I found "“Covalon achieved strong revenue growth, driven by the success of our US Medical Consumables business, which remains our

[prophetoffactz]

Today's news release: “We believe Covalon is undervalued — trading at a mid-single-digit Adjusted EBITDA multiple compared to med-tech peers in Canada and the U.S., which typically trade at

[Possibleidiot01]

Company is definitely not happy with the share price! "“We believe Covalon is undervalued — trading at a mid-single-digit Adjusted EBITDA multiple compared to med-tech peers in Canada and the U

[PressRelease]

Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, today announced that it has engaged Origin Merchant Partners as its financial and strategic advisor to advise on a range of opportunities aimed at maximizing shareholder...read article.

[PressRelease]

Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, is pleased to announce the promotion of Ms. Kim Crooks to the position of Chief Operating Officer (COO), effective immediately. In addition to her new role, Ms. Crooks has...read article.

[Possibleidiot01]

Thanks for the post which encouraged me as a shareholder to listen . The comment you mentioned is at the 23.50 or so mark for those of you who are like me , distrusting. You can check it. Brent Ashton

[PressRelease]

Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, today announced that it will be presenting at the 2025 Bloom Burton & Co. Healthcare Investor Conference in Toronto on Tuesday, May 6, 2025 at 2:30 pm ET in Room 104 B at...read article.

[prophetoffactz]

Did he say he's looking for the stock to double, on average, in each of the next five years? WoW!